Key Changes to Clinical Evaluation in China Webinar

In recent months, China’s regulator (NMPA) has issued updated guidance for the clinical evaluation of medical devices. These changes are subsequent to Order 739, which took effect in June 2021 and mandated a comprehensive set of changes to China’s medical device regulations. This webinar will take a deep dive into the evolving regulations on clinical evaluation, including discussion of: new clinical evaluation pathways, clinical evaluation principles and processes, clinical evaluation report (CER), clinical trials and GCP updates. Attendees will also learn about the unique clinical evaluation guidelines for IVDs. This webinar is free for AdvaMed members. Click here to register.